Notre groupe organise plus de 3 000 séries de conférences Événements chaque année aux États-Unis, en Europe et en Europe. Asie avec le soutien de 1 000 autres Sociétés scientifiques et publie plus de 700 Open Access Revues qui contiennent plus de 50 000 personnalités éminentes, des scientifiques réputés en tant que membres du comité de rédaction.

Les revues en libre accès gagnent plus de lecteurs et de citations
700 revues et 15 000 000 de lecteurs Chaque revue attire plus de 25 000 lecteurs

Abstrait

Macrophage Models for Tuberculosis Studies

Wei T, Li F, Huang Q, Bao F and Liu A

Setting: Macrophage models create an environment for the growth of Mycobacterium tuberculosis and can be applied to studies on the intracellular pathogen. Objective: To review macrophage models for tuberculosis studies in terms of the cell sources and applications. Methods: The online English database PubMed, Chinese databases such as CNKI, SinoMed, and Wanfang were searched up to December 2010 for published articles. Two groups of terms were used for the information retrieval, one of which includes macrophage model, macrophages model, macrophage models, macrophages models, macrophage, and macrophages; the other group of terms comprises Mycobacterium tuberculosis. For PubMed, the two groups of English terms were applied, while for the Chinese databases, related Chinese terms were used. Results: Cell sources of macrophage models include murine bone marrows, human peripheral blood, human lungs, and cell lines. The screened antituberculosis drugs are Western drugs such as ciprofloxacin and ofloxacin, and traditional Chinese medications like pittosporum brevicalyx (oliv.) gagnep and ranunculus ternatus thunb. The regulation of SigB and SigF was described in the pathogenesis of tuberculosis, while pknE mutant modifying the innate immune response in immuno-mechanism of tuberculosis. Conclusions:There are four major cell sources for developing a macrophage model, which can be applied to studies on screening both Western and Chinese anti-TB drugs, figuring out the pathogenesis and immunemechanism of TB with some key issues remaining to be dealt with.

Avertissement: Ce résumé a été traduit à l'aide d'outils d'intelligence artificielle et n'a pas encore été examiné ni vérifié.